|
MGRX Mangoceuticals Inc 1938046 |
| Income Statement |
|
Revenue
|
form10-q
|
133,368 |
|
Net Income
|
form10-q
|
-1,999,233 |
|
Profit Margin
|
|
-1499.04% |
| Balance Sheet |
|
Current Assets
|
104,067 |
|
Assets
|
14,792,041 |
|
Current Liabilities
|
1,391,382 |
|
Liabilities
|
1,403,549 |
|
Equity
|
13,388,492 |
|
Shares Out
|
29,906,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-3,734,201 |
|
Investing Cash Flow
|
65,000 |
| Market Analysis |
Market Cap
|
7,670,840 |
|
Price
|
4.22 |
|
BVPS
|
0.45 |
|
PB
|
10.05 |
|
EPS
|
-0.44 |
|
PS
|
14.38 |
|
FCF
|
-3,669,201 |
|
| Earnings |
|
| Apr |
May |
Jun |
| 4/01 |
|
5/15 |
-0.10 |
|
|
|
| Oct |
Nov |
Dec |
| 10/24 |
|
11/14 |
-0.99 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MGRX documents filed with the SEC.
MGRX Filings
Clear
